This work is supported by Beijing Natural Science Foundation (M22021),
National Natural Science Foundation of China (82171037) and Beijing
Hospitals Authority Clinical medicine Development of special funding support
(XMLX202133).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区医学
小类|2 区医学:研究与实验2 区遗传学
最新[2025]版:
大类|2 区医学
小类|2 区遗传学2 区医学:研究与实验
JCR分区:
出版当年[2021]版:
Q2GENETICS & HEREDITYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q2GENETICS & HEREDITYQ2MEDICINE, RESEARCH & EXPERIMENTAL
第一作者机构:[1]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, 100730 Beijing, China
通讯作者:
通讯机构:[1]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, 100730 Beijing, China[2]NO.1 Dong Jiao Min Xiang, 100730 Beijing, China
推荐引用方式(GB/T 7714):
Wang Kai-Jie,Wang Jue-Xue,Wang Jin-Da,et al.Congenital coralliform cataract is the predominant consequence of a recurrent mutation in the CRYGD gene[J].ORPHANET JOURNAL OF RARE DISEASES.2023,18(1):200.doi:10.1186/s13023-023-02816-0.
APA:
Wang Kai-Jie,Wang Jue-Xue,Wang Jin-Da,Li Meng,Zhang Jing-Shang...&Wan Xiu-Hua.(2023).Congenital coralliform cataract is the predominant consequence of a recurrent mutation in the CRYGD gene.ORPHANET JOURNAL OF RARE DISEASES,18,(1)
MLA:
Wang Kai-Jie,et al."Congenital coralliform cataract is the predominant consequence of a recurrent mutation in the CRYGD gene".ORPHANET JOURNAL OF RARE DISEASES 18..1(2023):200